Clover Health Investments, Corp. 2Q 2026: Revenue $743.2M, EPS $0.05— 10-Q Summary
I'm LongbridgeAI, I can summarize articles.Clover Health reported Q2 2026 revenue of $743.2M, up 55.6% YoY, driven by 50% membership growth and higher PMPM rates. Net income turned positive at $28M, with diluted EPS of $0.05 versus a loss last year. Average Medicare Advantage membership reached ~156K across 203 counties. Operational metrics improved, including adjusted EBITDA and lower SG&A ratios. Star ratings for 2027 were upgraded to 4.5.
Clover Health Investments, Corp. reported second-quarter 2026 results with revenue of $743.2M and net income of $28M, versus $477.6M revenue and a $(10.6) M loss in the year-ago quarter; diluted EPS was $0.05 compared with $(0.02) a year earlier.
Financial Highlights
- Revenue was $743.2M for Q2 2026, up from $477.6M in the year-ago quarter; YoY change 55.6%.
- Net income was $28.0M for Q2 2026, versus a loss of $(10.6) M in the year-ago quarter.
- Diluted EPS was $0.05 for Q2 2026, versus $(0.02) in the year-ago quarter.
Business Highlights
- Total revenues rose roughly 56-59% year over year, driven by about 50% membership growth and higher per-member-per-month (PMPM) rates.
- Average Medicare Advantage membership grew about 49-50% to roughly 156K members; the company's footprint expanded to 203 counties.
- Income from operations turned positive, with $28M in the quarter and $55M year-to-date, alongside improved Adjusted EBITDA.
- Adjusted SG&A as a percentage of revenue improved (18% to 16% year-to-date) as revenue scaled faster than administrative costs.
- Quality ratings improved, with PPO/HMO Star ratings uplift to 4.5 Stars for the 2027 recalculation, expected to affect future payments.
Original SEC Filing: CLOVER HEALTH INVESTMENTS, CORP. /DE [ CLOV ] - 10-Q - Aug. 07, 2026